YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Swiss pharmaceutical company Novartis AG plans to buy French drugmaker Advanced Accelerator Applications for $3.9 billion.
Advanced Accelerator Application develops molecular nuclear medicine, including Lutathera. It was approved in Europe in September to fight gastroenteropancreatic neuroendocrine tumors.
The deal was approved by Advanced Accelerator Application's board of directors.
Read more from TheStreet.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach